Annual Operating Expenses
$458.07 M
+$42.64 M+10.26%
December 31, 2024
Summary
- As of March 12, 2025, AGIO annual total operating expenses is $458.07 million, with the most recent change of +$42.64 million (+10.26%) on December 31, 2024.
- During the last 3 years, AGIO annual operating expenses has risen by +$79.65 million (+21.05%).
- AGIO annual operating expenses is now at all-time high.
Performance
AGIO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$134.51 M
+$23.52 M+21.19%
December 31, 2024
Summary
- As of March 12, 2025, AGIO quarterly total operating expenses is $134.51 million, with the most recent change of +$23.52 million (+21.19%) on December 31, 2024.
- Over the past year, AGIO quarterly operating expenses has increased by +$21.71 million (+19.25%).
- AGIO quarterly operating expenses is now -3.77% below its all-time high of $139.78 million, reached on June 30, 2019.
Performance
AGIO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AGIO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.3% | +19.3% |
| 3 y3 years | +21.1% | +19.3% |
| 5 y5 years | +44.8% | +19.3% |
AGIO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.1% | at high | +43.0% |
| 5 y | 5-year | at high | +44.8% | at high | +257.2% |
| alltime | all time | at high | +1090.8% | -3.8% | +257.2% |
Agios Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $458.07 M(+10.3%) | $134.51 M(+21.2%) |
| Sep 2024 | - | $110.99 M(-1.7%) |
| Jun 2024 | - | $112.94 M(+13.4%) |
| Mar 2024 | - | $99.63 M(-11.7%) |
| Dec 2023 | $415.43 M(+3.4%) | $112.79 M(+4.8%) |
| Sep 2023 | - | $107.66 M(+8.4%) |
| Jun 2023 | - | $99.30 M(+3.8%) |
| Mar 2023 | - | $95.67 M(-7.2%) |
| Dec 2022 | $401.58 M(+6.1%) | $103.07 M(+9.5%) |
| Sep 2022 | - | $94.09 M(-8.5%) |
| Jun 2022 | - | $102.79 M(+1.1%) |
| Mar 2022 | - | $101.64 M(-3.0%) |
| Dec 2021 | $378.42 M(+12.7%) | $104.83 M(+15.0%) |
| Sep 2021 | - | $91.15 M(-0.1%) |
| Jun 2021 | - | $91.22 M(+0.0%) |
| Mar 2021 | - | $91.22 M(+6.9%) |
| Dec 2020 | $335.92 M(+6.2%) | $85.33 M(+6.3%) |
| Sep 2020 | - | $80.29 M(-3.6%) |
| Jun 2020 | - | $83.26 M(-4.3%) |
| Mar 2020 | - | $87.03 M(-201.7%) |
| Dec 2019 | $316.27 M(-30.6%) | -$85.58 M(-163.5%) |
| Sep 2019 | - | $134.69 M(-3.6%) |
| Jun 2019 | - | $139.78 M(+9.7%) |
| Mar 2019 | - | $127.38 M(+1.4%) |
| Dec 2018 | $455.47 M | $125.67 M(+10.6%) |
| Sep 2018 | - | $113.67 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $113.36 M(+10.3%) |
| Mar 2018 | - | $102.77 M(+2.8%) |
| Dec 2017 | $363.81 M(+34.3%) | $99.93 M(+10.6%) |
| Sep 2017 | - | $90.38 M(-5.8%) |
| Jun 2017 | - | $95.95 M(+23.7%) |
| Mar 2017 | - | $77.56 M(-3.1%) |
| Dec 2016 | $270.88 M(+52.3%) | $80.06 M(+10.4%) |
| Sep 2016 | - | $72.50 M(+14.3%) |
| Jun 2016 | - | $63.45 M(+15.6%) |
| Mar 2016 | - | $54.88 M(+16.5%) |
| Dec 2015 | $177.82 M(+48.8%) | $47.12 M(+2.5%) |
| Sep 2015 | - | $45.95 M(+1.3%) |
| Jun 2015 | - | $45.35 M(+15.1%) |
| Mar 2015 | - | $39.40 M(-4.8%) |
| Dec 2014 | $119.49 M(+85.5%) | $41.36 M(+34.8%) |
| Sep 2014 | - | $30.69 M(+14.8%) |
| Jun 2014 | - | $26.74 M(+29.2%) |
| Mar 2014 | - | $20.70 M(+9.0%) |
| Dec 2013 | $64.43 M(+33.9%) | $18.99 M(+9.5%) |
| Sep 2013 | - | $17.34 M(+17.2%) |
| Jun 2013 | - | $14.79 M(+11.1%) |
| Mar 2013 | - | $13.31 M(+4.2%) |
| Dec 2012 | $48.10 M(+25.0%) | $12.78 M(+12.3%) |
| Sep 2012 | - | $11.38 M(-8.3%) |
| Jun 2012 | - | $12.41 M(+7.6%) |
| Mar 2012 | - | $11.53 M |
| Dec 2011 | $38.47 M | - |
FAQ
- What is Agios Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual operating expenses year-on-year change?
- What is Agios Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly operating expenses year-on-year change?
What is Agios Pharmaceuticals annual total operating expenses?
The current annual operating expenses of AGIO is $458.07 M
What is the all time high annual operating expenses for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual total operating expenses is $458.07 M
What is Agios Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, AGIO annual total operating expenses has changed by +$42.64 M (+10.26%)
What is Agios Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of AGIO is $134.51 M
What is the all time high quarterly operating expenses for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly total operating expenses is $139.78 M
What is Agios Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, AGIO quarterly total operating expenses has changed by +$21.71 M (+19.25%)